Jen‐Chieh Tseng
Impact in
- Oncology top 5%
- Peptidase Inhibition and Analysis
- Rehabilitation top 5%
- Wound Healing and Treatments
Papers in
-
- Histone Deacetylase Inhibitors Research 5
- Protein Degradation and Inhibitors 3
- bioluminescence and chemiluminescence research 3
- Oncology 8
- Peptidase Inhibition and Analysis 5
- Co-authors
- Andrew L. Kung (17 shared papers)Daniel Meruelo (8 shared papers)Kenneth C. Anderson (4 shared papers)Ralph Mazitschek (5 shared papers)Teru Hideshima (5 shared papers)Scott J. Rodig (5 shared papers)James E. Bradner (3 shared papers)Walter C. Ogier (2 shared papers)
- Journals
- Molecular Imaging and Biology (3 papers)Blood (3 papers)Journal of Clinical Oncology (2 papers)PLoS ONE (2 papers)Molecular Therapy (2 papers)
- Partner nations
- United StatesBelgiumCanada
In The Last Decade
Jen‐Chieh Tseng
35 papers receiving 1.6k citations
Jen‐Chieh Tseng's Hit Papers
Peers
Comparison fields: 5 of 97
- Oncology 401
- Rehabilitation 96
- Hematology 162
- Molecular Biology 945
- Genetics 259
Countries citing papers authored by Jen‐Chieh Tseng
This map shows the geographic impact of Jen‐Chieh Tseng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jen‐Chieh Tseng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jen‐Chieh Tseng more than expected).
Fields of papers citing papers by Jen‐Chieh Tseng
This network shows the impact of papers produced by Jen‐Chieh Tseng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jen‐Chieh Tseng. The network helps show where Jen‐Chieh Tseng may publish in the future.
Co-authors
The 25 scholars most cited alongside Jen‐Chieh Tseng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Preclinical activity, pharmacodynamic, and pharmacokinetic properties of a selective HDAC6 inhibitor, ACY-1215, in combination with bortezomib in multiple myeloma Hit paper breakdown → | 2012 | 489 |
| 2 | 1995 | 179 | |
| 3 | 2011 | 132 | |
| 4 | 2003 | 121 | |
| 5 | 2011 | 90 | |
| 6 | 2012 | 75 | |
| 7 | 2009 | 62 | |
| 8 | 2002 | 54 | |
| 9 | 2004 | 51 | |
| 10 | 2014 | 41 | |
| 11 | 2015 | 37 | |
| 12 | 2017 | 32 | |
| 13 | 2015 | 28 | |
| 14 | Tumor-specific in vivo transfection with HSV-1 thymidine kinase gene using a Sindbis viral vector as a basis for prodrug ganciclovir activation and PET. | 2006 | 27 |
| 15 | 2011 | 24 | |
| 16 | 2015 | 23 | |
| 17 | 2013 | 23 | |
| 18 | 2012 | 21 | |
| 19 | 2006 | 17 | |
| 20 | 2014 | 14 |
About Jen‐Chieh Tseng
Jen‐Chieh Tseng is a scholar working on Molecular Biology, Oncology, Genetics, Immunology and Hematology, having authored 35 papers that have together received 1.6k indexed citations. Recurring topics across this work include Virus-based gene therapy research (7 papers), Histone Deacetylase Inhibitors Research (5 papers), Peptidase Inhibition and Analysis (5 papers), Protein Degradation and Inhibitors (3 papers), Immune Cell Function and Interaction (3 papers), Acute Lymphoblastic Leukemia research (3 papers), bioluminescence and chemiluminescence research (3 papers) and Nanoplatforms for cancer theranostics (3 papers). The work is most often cited by research in Oncology (401 citations), Rehabilitation (96 citations), Hematology (162 citations), Molecular Biology (945 citations) and Genetics (259 citations). Jen‐Chieh Tseng has collaborated with scholars based in United States, Belgium and Canada. Frequent co-authors include Andrew L. Kung, Daniel Meruelo, Kenneth C. Anderson, Ralph Mazitschek, Teru Hideshima, Scott J. Rodig, James E. Bradner, Walter C. Ogier, Tyler Scullen and John H. van Duzer. Their work appears in journals such as Molecular Imaging and Biology, Blood, Journal of Clinical Oncology, PLoS ONE and Molecular Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.